• The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
  • This web site is a service of Prostate Cancer International.

    pcai_cmyk

  • Other PCI web sites

  • The "New" Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services.

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The "New" Prostate Cancer InfoLink is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

    • Perspective Confidentiality Disclosure Reliability Courtesy

Risk + Prevention

Contents of This Section

Summary Overview

There is no 100 percent safe and proven way that men can use to prevent prostate cancer, and many things (including age, genetics, race, and environment) may affect your risk for this disease. In fact, it is completely normal for most men to have a small focus of prostate cancer by the time they get into their 70s or 80s today, and it may never need treatment!

We do, however, now have data, from two major, completed, randomized, double-blind clinical trials carried out to investigate the potential of two different drugs to prevent prostate cancer. The Prostate Cancer Prevention Trial  (PCPT) showed that finasteride, a type of drug known as a 5α-reductase inhibitor or 5-ARI, reduced the risk of prostate cancer in men by about a quarter. The REDUCE trial showed that dutasteride, another, newer type of 5-ARI, also reduced the risk  for prostate cancer by about the same amount (in a higher risk group of men). And in February 2009 a guideline was issued recommending that men discuss the potential use of 5-ARIs to prevent prostate cancer with their doctors.

There is no good evidence that taking supplements or micro-nutrients can prevent prostate cancer. Lycopene and tomatoes haven’t been proven to work either. In 2008 the SELECT trial, designed to investigate the potential of selenium and vitamin E, was stopped because there was no sign of any significant benefits, and certain risks seemed to outweigh any even minimal benefits. In addition, in early 2009, the Physicians Health Study II demonstrated that neither vitamin E nor vitamin C had any impact on prevention of prostate cancer.

What we also have today is some preliminary evidence that baseline PSA levels taken in early middle age may offer an indicator of long-term risk for the development of prostate cancer. In addition, the PCPT prostate cancer risk calculator and the Sunnybrook risk calulator both offer ways for a man and his primary care physician to assess his risk for prostate cancer and therefore the need for a prostate biopsy based on things like his PSA and DRE results.

If you take Proscar (finasteride) or Avodart (dutasteride) for benign prostatic hyperplasia (BPH), you should make sure your doctor knows this because they may affect your PSA levels. Perhaps more importantly, so may Propecia, a drug many men take to deal with hair loss (“male pattern baldness”). Make sure you tell you doctor if you use Propecia too.

This section of The “New” Prostate Cancer InfoLink will seek to keep you up to date with any useful information about  ways to prevent prostate cancer or at least lower men’s risk for this disease. For starters, have a look at Prevention: an introduction. We have also posted details about the guideline on use of 5-ARIs in the prevention of prostate cancer, as well as summaries of the key findings of the PCPT trial, the REDUCE trial, the SELECT trial, as well as information about the  toremifene/PIN prevention trial — the only other large, ongoing trial that is currently seeking to define the potential for prostate cancer prevention.

Content of this page last reviewed and updated May 24, 2009